MAPT and Mental deterioration: Increased levels of total Tau, phosphorylated Thr181 Tau, and Aβ42 in neurally derived blood EVs were demonstrated to be an early marker for AD and cognitive decline progression, thus supporting the use of circulating EVs as a sort of “liquid biopsy” [37,38,39].